Circulating Tumor DNA Analysis Depicts Potential Mechanisms of Resistance to BRAF-Targeted Therapies in BRAF plus Non-Small Cell Lung Cancer

被引：4

作者：

Ortiz-Cuaran, S. ^{[1
]}

Mezquita, L. ^{[2
]}

Swalduz, A. ^{[3
]}

Aldea, M. ^{[2
]}

Mazieres, J. ^{[4
]}

Jovelet, C. ^{[5
]}

Flores, W. R. Chumbi ^{[6
]}

Lacroix, L. ^{[7
]}

Loriot, Y. ^{[2
]}

Friboulet, L. ^{[2
]}

Westeel, V. ^{[8
]}

Ngocamus, M. ^{[9
]}

Pradines, A. ^{[10
]}

Tissot, C. ^{[11
]}

Duchene, C. Clement ^{[12
]}

Raynaud, C. ^{[13
]}

Quantin, X. ^{[14
]}

Gervais, R. ^{[15
]}

Brain, E. ^{[16
]}

Monnet, I. ^{[17
]}

Leprieur, E. Giroux ^{[18
]}

Avrillon, V. ^{[19
]}

Oukhatar, C. Mahier-Ait ^{[20
]}

Hoog-Labouret, N. ^{[21
]}

De Kievit, F. ^{[22
]}

Howarth, K. ^{[22
]}

Guichou, J. ^{[23
]}

Morris, C. ^{[22
]}

Green, E. ^{[22
]}

Perol, M. ^{[24
]}

Besse, B. ^{[25
]}

Blay, J. ^{[3
]}

Saintigny, P. ^{[1
]}

Planchard, D. ^{[26
]}

机构：

[1] Ctr Leon Berard, Canc Res Ctr Lyon, Translat Res, Lyon, France

[2] Gustave Roussy, Med Oncol Dept, Villejuif, France

[3] Ctr Leon Berard, Med Oncol, Lyon, France

[4] CHU Toulouse, Toulouse, France

[5] Gustave Roussy, Genom Dept, Villejuif, France

[6] Hosp Civils Lyon, Serv Pneumol, Lyon, France

[7] Gustave Roussy, Med Biol & Pathol, Villejuif, France

[8] Univ Hosp Besancon, Reg Inst Canc, Besancon, France

[9] Gustave Roussy, Villejuif, France

[10] Inst Claudius Regaud, Biol Med Oncol, Toulouse, France

[11] Univ Hosp St Etienne, St Etienne, France

[12] Hop Brabois, Vandoeuvre Les Nancy, France

[13] Inst Mutualiste Montsouris, Paris, France

[14] Univ Hosp Montpellier, Montpellier, France

[15] Ctr Francois Baclesse, Caen, France

[16] Hop Rene Huguenin, St Cloud, France

[17] Chi Creteil, Pneumol, Creteil, France

[18] AP HP, Ambroise Pare Ctr, Paris, France

[19] Ctr Leon Berard, Lyon, France

[20] Unicancer, Paris, France

[21] Inst Natl Canc, Boulogne, France

[22] Inivata Ltd, Cambridge, England

[23] Univ Montpellier, CNRS, INSERM, Cbs, Montpellier, France

[24] Ctr Leon Berard, Dept Thorac Oncol, Lyon, France

[25] Inst Gustave Roussy, Med Oncol, Thorac Grp, Villejuif, France

[26] Gustave Roussy, Thorac Grp, Dept Med Oncol, Villejuif, France

来源：

JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期

关键词：

braf; resistance; circulating-tumor DNA;

D O I：

10.1016/j.jtho.2019.08.678

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

MA21.07

引用

页码：S337 / S337

页数：1

共 50 条

[31] Molecular mechanisms of resistance to BRAF and MEK inhibitors in BRAFV600E non-small cell lung cancer
Facchinetti, Francesco
Lacroix, Ludovic
Mezquita, Laura
Scoazec, Jean-Yves
Loriot, Yohann
Tselikas, Lambros
Gazzah, Anas
Rouleau, Etienne
Adam, Julien
Michiels, Stefan
Massard, Christophe
Andre, Fabrice
Olaussen, Ken A.
Vassal, Gilles
Howarth, Karen
Besse, Benjamin
Soria, Jean-Charles
Friboulet, Luc
Planchard, David
EUROPEAN JOURNAL OF CANCER, 2020, 132 : 211 - 223
[32] Dynamics of multiple resistance mechanisms in plasma DNA during EGFR-targeted therapies in non-small cell lung cancer
Tsui, Dana Wai Yi
Murtaza, Muhammed
Wong, Alvin Seng Cheong
Rueda, Oscar M.
Smith, Christopher G.
Chandrananda, Dineika
Soo, Ross A.
Lim, Hong Liang
Goh, Boon Cher
Caldas, Carlos
Forshew, Tim
Gale, Davina
Liu, Wei
Morris, James
Marass, Francesco
Eisen, Tim
Chin, Tan Min
Rosenfeld, Nitzan
EMBO MOLECULAR MEDICINE, 2018, 10 (06)
[33] Detection and application of circulating tumor cell and circulating tumor DNA in the non-small cell lung cancer
Zhang, Yuting
Zheng, Hongmei
Zhan, Yuting
Long, Mengping
Liu, Sile
Lu, Junmi
Zang, Hongjing
Fan, Songqing
AMERICAN JOURNAL OF CANCER RESEARCH, 2018, 8 (12): : 2377 - 2386
[34] Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancer
Jingying Nong
Yuhua Gong
Yanfang Guan
Xin Yi
Yuting Yi
Lianpeng Chang
Ling Yang
Jialin Lv
Zhirong Guo
Hongyan Jia
Yuxing Chu
Tao Liu
Ming Chen
Lauren Byers
Emily Roarty
Vincent K. Lam
Vassiliki A. Papadimitrakopoulou
Ignacio Wistuba
John V. Heymach
Bonnie Glisson
Zhongxing Liao
J. Jack Lee
P. Andrew Futreal
Shucai Zhang
Xuefeng Xia
Jianjun Zhang
Jinghui Wang
Nature Communications, 9
[35] Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancer
Nong, Jingying
Gong, Yuhua
Guan, Yanfang
Yi, Xin
Yi, Yuting
Chang, Lianpeng
Yang, Ling
Lv, Jialin
Guo, Zhirong
Jia, Hongyan
Chug, Yuxing
Liu, Tao
Chen, Ming
Byers, Lauren
Roarty, Emily
Lam, Vincent K.
Papadimitrakopoulou, Vassiliki A.
Wistuba, Ignacio
Heymach, John, V
Glisson, Bonnie
Liao, Zhongxing
Lee, J. Jack
Futreal, P. Andrew
Zhang, Shucai
Xia, Xuefeng
Zhang, Jianjun
Wang, Jinghui
NATURE COMMUNICATIONS, 2018, 9
[36] Molecular Mechanisms and Targeted Therapies Including Immunotherapy for Non-Small Cell Lung Cancer
Nagano, Tatsuya
Tachihara, Motoko
Nishimura, Yoshihiro
CURRENT CANCER DRUG TARGETS, 2019, 19 (08) : 595 - 630
[37] Resistance Mechanisms to Targeted Therapies in ROS1+ and ALK+ Non-small Cell Lung Cancer
McCoach, Caroline E.
Le, Anh T.
Gowan, Katherine
Jones, Kenneth
Schubert, Laura
Doak, Andrea
Estrada-Bernal, Adriana
Davies, Kurtis D.
Merrick, Daniel T.
Bunn, Paul A., Jr.
Purcell, W. Tom
Dziadziuszko, Rafal
Varella-Garcia, Marileila
Aisner, Dara L.
Camidge, D. Ross
Doebele, Robert C.
CLINICAL CANCER RESEARCH, 2018, 24 (14) : 3334 - 3347
[38] RAS and BRAF in the foreground for non-small cell lung cancer and colorectal cancer: Similarities and main differences for prognosis and therapies
Giopanou, Ioanna
Pintzas, Alexandros
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2020, 146
[39] Application of Circulating Tumor DNA as a Biomarker for Non-Small Cell Lung Cancer
Yang, Jialiang
Hui, Yan
Zhang, Yanxiang
Zhang, Minghui
Ji, Binbin
Tian, Geng
Guo, Yangqiang
Tang, Min
Li, Lianxing
Guo, Bella
Ma, Tonghui
FRONTIERS IN ONCOLOGY, 2021, 11
[40] Circulating tumor DNA testing in advanced non-small cell lung cancer
Moding, Everett J.
Diehn, Maximilian
Wakelee, Heather A.
LUNG CANCER, 2018, 119 : 42 - 47

← 1 2 3 4 5 →